Irenic Capital Management LP Buys New Holdings in Integer Holdings Corporation $ITGR

Irenic Capital Management LP bought a new stake in Integer Holdings Corporation (NYSE:ITGR) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,263,663 shares of the medical equipment provider’s stock, valued at approximately $99,109,000. Integer comprises about 6.7% of Irenic Capital Management LP’s portfolio, making the stock its biggest holding.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. William Blair Investment Management LLC acquired a new position in shares of Integer during the third quarter worth about $28,459,000. Heartland Advisors Inc. lifted its stake in shares of Integer by 506.8% during the fourth quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock worth $19,036,000 after purchasing an additional 202,715 shares in the last quarter. Magnetar Financial LLC acquired a new position in shares of Integer during the third quarter worth about $1,890,000. Tudor Investment Corp ET AL lifted its stake in shares of Integer by 50,787.5% during the third quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after purchasing an additional 29,442,029 shares in the last quarter. Finally, Jennison Associates LLC acquired a new position in shares of Integer during the fourth quarter worth about $1,036,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on ITGR. Wells Fargo & Company boosted their price objective on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research note on Friday, February 20th. Zacks Research cut Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Truist Financial boosted their price objective on Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Friday, February 20th. Piper Sandler restated an “overweight” rating and set a $97.00 price objective (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Finally, Citigroup boosted their price objective on Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a research note on Thursday, May 28th. Four equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $98.71.

Integer Stock Down 1.8%

Shares of NYSE ITGR opened at $89.70 on Thursday. Integer Holdings Corporation has a 1 year low of $62.00 and a 1 year high of $123.78. The firm has a market cap of $3.05 billion, a price-to-earnings ratio of 22.37, a PEG ratio of 2.18 and a beta of 0.66. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The stock’s 50-day simple moving average is $88.69 and its 200-day simple moving average is $84.61.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The business had revenue of $439.58 million for the quarter, compared to analysts’ expectations of $426.48 million. During the same period in the previous year, the firm posted $1.31 earnings per share. The firm’s revenue was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities analysts anticipate that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.